search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
EXHIBITION PREVIEW bioMérieux. Cepheid.


efficient process. Powered by a unique


high-performance laser system for consistent ion excitation and extended lifespan, the TX8 ensures exceptional sensitivity and resolution. Its AIEF and TAA technologies enhance analytical performance while maintaining a compact, lightweight design


bioMérieux As a world leader in microbiology for more than 60 years, bioMérieux remains commited to tackling major public health challenges in infectious diseases, including antimicrobial resistance, respiratory infections, and sepsis. The company continues to deliver


comprehensive end-to-end diagnostic solutions that support improved patient outcomes, help prevent antimicrobial resistance, and strengthen antimicrobial stewardship across healthcare systems. Its integrated IT and data tools empower laboratories and clinicians with timely, actionable insights to guide confident decision making. At BSMT 2026, bioMérieux is proud


to be highlighting its evolving portfolio of innovative diagnostic technologies designed to support the needs of modern microbiology laboratories today and into the future. www.biomerieux.com


Bruker UK Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with


customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and


Bruker UK.


nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as clinical microbiology and molecular diagnostics. www.bruker.com


Cepheid Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company’s GeneXpert systems and Xpert tests automate highly complex and time-consuming manual procedures, providing a beter way for institutions of any size to perform world- class PCR testing. Cepheid’s broad test portfolio spans


respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare- associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near- patient setings. www.cepheid.com


Chirus


Chirus is proud to introduce the TX8 Maldi- ToF system, at just one meter in height the next- generation Automated Mass Spectrometry Microbial Identification System is designed to deliver speed, accuracy, and intelligent performance in one compact solution. Combining advanced MALDI-TOF technology with intuitive touch-screen control, the TX8 transforms microbial identification into a seamless, highly


suitable for any laboratory environment. The system features an extensive


identification library covering 5,286 species and 18,934 strains across clinical, industrial, aquatic, and intestinal fields. With an E-MT hash matching algorithm delivering database searches in just 0.1 seconds, results are fast, reliable, and precise.


Smart capabilities including facial-


recognition login, audit tracking, self- diagnostic safety protection, and ASTM connectivity to LIMS systems make the TX8 a powerful, future-ready platform. www.chirus.com


Culture Collections The UK Health Security Agency (UKHSA) operates four internationally recognised Culture Collections of preserved, authenticated cell lines, bacteria, viruses and fungi. Maintained by highly skilled specialists and operated to ISO 9001:2015 quality standards, these resources provide scientists with trusted reference materials of known provenance. Researchers worldwide rely on Culture


Collections products for clinical diagnostic controls, antimicrobial susceptibility testing, food, water and environmental microbiology, and disease research. Bacterial and fungal strains are supplied as freeze-dried preparations, while viruses and cell lines are available as cryopreserved, viable cultures. Inactivated viruses, including SARS and Mpox, are also offered. In 2025, the National


Chirus.


Collection of Pathogenic Viruses (NCPV) marked its 25-year anniversary, reflecting its evolution into a strategic global resource since its establishment in 2000. NCPV now holds more than 340 authenticated virus strains spanning 19 families, supporting research, diagnostics and outbreak response, including


April 2026 WWW.PATHOLOGYINPRACTICE.COM 45


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56